Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Lynne M. George"'
1
Akademický článek
Antenatal screening for Down syndrome using serum placental growth factor with the combined, quadruple, serum integrated and integrated tests.
Autor: Nicholas J Wald, Jonathan P Bestwick, Lynne M George, Wayne J Huttly
Publikováno v: PLoS ONE, Vol 7, Iss 10, p e46955 (2012)
To estimate the value of first or second trimester placental growth factor (PlGF) as an additional antenatal screening marker for Down syndrome.Nested case-control study.Antenatal screening service.532 Down syndrome pregnancies and 1,155 matched unaf
Externí odkaz: https://doaj.org/article/767df37e1a4845c2b6eb82f85eef81e1
Zobrazit plný text záznamu
3
Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers
Autor: Tiesheng Wu, Lynne M. George, Jonathan P. Bestwick, Joan K. Morris, Nicholas J. Wald
Publikováno v: Journal of Medical Screening. 19:60-67
Objective To estimate the pre-eclampsia screening performance of placental growth factor (PlGF) and endoglin with second-trimester Quadruple test markers used for antenatal Down's syndrome screening. Methods A nested case-control study of 88 pregnant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf9258a758ee3cddf21e484923e20a4
https://doi.org/10.1258/jms.2012.011114
Zobrazit plný text záznamu
4
Validation plots in antenatal screening for Down's syndrome
Autor: Wayne J. Huttly, Jonathan P. Bestwick, Joan K. Morris, Lynne M. George, Nicholas J. Wald
Publikováno v: Journal of Medical Screening. 13:166-171
Objective To validate empirically the accuracy of antenatal Down's syndrome screening using the Integrated test, to compare this with other screening tests (including the Integrated test with the addition of cross trimester [CT] marker ratios) and to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59777249535a01c47c5befc6e944ba84
https://doi.org/10.1177/096914130601300402
Zobrazit plný text záznamu
5
Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies
Autor: Nicholas J. Wald, Joan K. Morris, Lynne M. George, Tiesheng Wu
Publikováno v: British Journal of Cancer
Insulin-like growth factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2), and insulin-like growth factor binding protein-3 (IGFBP-3) were measured in frozen serum samples from 1051 men with cancer and 3142 controls in a nested case–control study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af01116f3fb11fdde829ec71a5e41f8
http://europepmc.org/articles/PMC2360494
Zobrazit plný text záznamu
7
MATERNAL SERUM INHIBIN-A IN PREGNANCIES WITH INSULIN-DEPENDENT DIABETES MELLITUS: IMPLICATIONS FOR SCREENING FOR DOWN'S SYNDROME
Autor: Hilary Watt, Lynne M. George, Nicholas J. Wald
Publikováno v: Prenatal Diagnosis. 16:923-926
A nested case-control study using stored serum samples collected as part of a prospective study of the outcome of pregnancy was performed to investigate concentrations of (dimeric) inhibin-A in maternal serum between 15 and 22 weeks of pregnancy in 1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e6d9c16492015c8f3edbf62f7f0a295
https://doi.org/10.1002/(sici)1097-0223(199610)16:10<923::aid-pd970>3.0.co
Zobrazit plný text záznamu
8
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
Autor: Nicholas J. Wald, Lynne M. George, K Petterson, D S Smith, J. W. Densem
Publikováno v: BJOG: An International Journal of Obstetrics and Gynaecology. 103:407-412
Objective To determine the value of serum screening for Down's syndrome at 8–14 weeks of pregnancy using seven potential serum markers (alpha-fetoprotein, unconjugated oestriol, total human chorionic gonadotrophin (hCG), free α-hCG, free P-hCG, pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2dafb9218f254165a3144ba4cfee83c0
https://doi.org/10.1111/j.1471-0528.1996.tb09765.x
Zobrazit plný text záznamu
9
PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKER
Autor: Nicholas J. Wald, Shauthi Muttukrishna, Philip G. Knight, Lynne M. George, J. W. Densem
Publikováno v: Prenatal Diagnosis. 16:143-153
The value of measuring inhibin-A (a beta A dimer) with human chorionic gonadotrophin (total or the sub-units free a-hCG and free beta-hCG separately), alpha-fetoprotein (AFP), and unconjugated oestriol (uE3) was examined to determine the effect on th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::08a596175d04678df7485032aa303f45
https://doi.org/10.1002/(sici)1097-0223(199602)16:2<143::aid-pd825>3.0.co
Zobrazit plný text záznamu
10
The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia
Autor: Nicholas J. Wald, Jonathan P. Bestwick, Lynne M. George, Tiesheng Wu, Joan K. Morris
Publikováno v: Journal of medical screening. 19(1)
Objective To estimate the pre-eclampsia screening performance of PAPP-A (pregnancy-associated plasma protein-A) and ADAM12 (A Disintegrin And Metalloprotease 12) in the early second trimester of pregnancy. Methods Stored frozen serum samples from a p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be6ce000d8f227310770fdbca8d5dba
https://pubmed.ncbi.nlm.nih.gov/22357350
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje